US Patent Issued to Apogee Therapeutics on July 15 for "Antibodies that bind interleukin 13 and methods of use" (Massachusetts Inventors)

ALEXANDRIA, Va., July 16 -- United States Patent no. 12,358,979, issued on July 15, was assigned to Apogee Therapeutics Inc. (Waltham, Mass.).

"Antibodies that bind interleukin 13 and methods of use" was invented by Hussam H. Shaheen (Waltham, Mass.), Kenneth Evan Thompson (Waltham, Mass.), Peter Harwin (Waltham, Mass.) and Tomas Kiselak (Waltham, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Described herein are novel and improved antibodies that bind Interleukin 13 (IL-13) and methods of use thereof. In certain aspects, described herein are methods of inhibiting IL-13 biological activity. In certain aspects, described herein are pharmaceutical compositions comprising the anti-IL-13 antibodies. In ce...